INS-1: Phase II

Insmed Inc. (INSM), Richmond, Va.
Product: INS-1
Business: Metabolic
Therapeutic category: Metabolism
Target: Insulin signaling

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE